{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:45:26Z","timestamp":1770677126238,"version":"3.49.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":1012,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Putative subcomponent vaccines of severe acute respiratory syndrome coronavirus spike protein and ARNAX (TLR3-specific adjuvant for priming dendritic cells) were examined and compared with spike protein + Alum in a mouse BALB\/c model. Survival, body weight, virus-neutralizing Ab titer in the blood, and viral titer in the lung were evaluated for prognosis markers. The infiltration degrees of eosinophils in the lung were histopathologically monitored at 10 d postinfection. The results were: (1) adjuvant was essential in vaccines to achieve a complete recovery from infection, (2) ARNAX displayed optimal body weight recovery compared with Alum, (3) ARNAX was optimal for the amelioration of eosinophilic pneumonia, and (4) the eosinophil infiltration score was not associated with the neutralizing Ab titer in the blood or viral titer in the lung. Although the pathological link between the TLR3 vaccine and lung eosinophil infiltration remains unclear, severe acute respiratory syndrome\u2013mediated eosinophilic pneumonia can be blocked by the prior induction of dendritic cell priming by ARNAX.<\/jats:p>","DOI":"10.4049\/immunohorizons.2200020","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T15:24:00Z","timestamp":1653319440000},"page":"275-282","source":"Crossref","is-referenced-by-count":10,"title":["Prophylactic Vaccine Targeting TLR3 on Dendritic Cells Ameliorates Eosinophilic Pneumonia in a Mouse SARS-CoV Infection Model"],"prefix":"10.1093","volume":"6","author":[{"given":"Naoko","family":"Iwata-Yoshikawa","sequence":"first","affiliation":[{"name":"Department of Pathology, National Institute of Infectious Diseases , Musashimurayama, Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyo","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Institute of Infectious Diseases , Musashimurayama, Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Takaki","sequence":"additional","affiliation":[{"name":"Department of Vaccine Immunology, Hokkaido University Graduate School of Medicine , Sapporo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4333-5260","authenticated-orcid":false,"given":"Misako","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Vaccine Immunology, Hokkaido University Graduate School of Medicine , Sapporo ,","place":["Japan"]},{"name":"Nebuta Research Institute for Life Sciences, Aomori University , Aomori ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadaki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Institute of Infectious Diseases , Musashimurayama, Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Institute of Infectious Diseases , Musashimurayama, Tokyo ,","place":["Japan"]},{"name":"Influenza Virus Research Center, National Institute of Infectious Diseases , Musashimurayama, Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0808-5710","authenticated-orcid":false,"given":"Tsukasa","family":"Seya","sequence":"additional","affiliation":[{"name":"Department of Vaccine Immunology, Hokkaido University Graduate School of Medicine , Sapporo ,","place":["Japan"]},{"name":"Nebuta Research Institute for Life Sciences, Aomori University , Aomori ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"2025010703513471100_r1","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"2025010703513471100_r2","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"2025010703513471100_r3","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1303729","article-title":"Family cluster of Middle East respiratory syndrome coronavirus infections","volume":"368","author":"Memish","year":"2013","journal-title":"N. Engl. J. Med"},{"key":"2025010703513471100_r4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"2025010703513471100_r5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bbrc.2004.10.052","article-title":"Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry","volume":"325","author":"He","year":"2004","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"2025010703513471100_r6","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults","volume":"383","author":"Anderson","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"2025010703513471100_r7","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"2025010703513471100_r8","article-title":"Study of monovalent and bivalent recombinant protein vaccines against COVID-19 in adults 18 years of age and older (VAT00008)","author":"Sanofi Pasteur, a Sanofi Company","year":"2021"},{"key":"2025010703513471100_r9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2019.07.008","article-title":"A Toll-like receptor 3 (TLR3) agonist ARNAX for therapeutic immunotherapy","volume":"147","author":"Seya","year":"2019","journal-title":"Adv. Drug Deliv. Rev"},{"key":"2025010703513471100_r10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"NPJ Vaccines"},{"key":"2025010703513471100_r11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature04734","article-title":"Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses","volume":"441","author":"Kato","year":"2006","journal-title":"Nature"},{"key":"2025010703513471100_r12","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1016\/j.vaccine.2020.05.064","article-title":"Consensus summary report for CEPI\/BC March 12-13, 2020 meeting: assessment of risk of disease enhancement with COVID-19 vaccines","volume":"38","author":"Lambert","year":"2020","journal-title":"Vaccine"},{"key":"2025010703513471100_r13","first-page":"65","volume-title":"Viruses: Biology, Application and Control","author":"Harper","year":"2012"},{"key":"2025010703513471100_r14","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1128\/JVI.00983-14","article-title":"Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB\/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine","volume":"88","author":"Iwata-Yoshikawa","year":"2014","journal-title":"J. Virol"},{"key":"2025010703513471100_r15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/1348-0421.12754","article-title":"Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs","volume":"64","author":"Sekimukai","year":"2020","journal-title":"Microbiol. Immunol"},{"key":"2025010703513471100_r16","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1099\/0022-1317-68-5-1233","article-title":"Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins","volume":"68","author":"Matsuura","year":"1987","journal-title":"J. Gen. Virol"},{"key":"2025010703513471100_r17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jviromet.2005.01.028","article-title":"Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS","volume":"125","author":"Saijo","year":"2005","journal-title":"J. Virol. Methods"},{"key":"2025010703513471100_r18","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.4049\/jimmunol.171.6.3154","article-title":"Subcellular localization of Toll-like receptor 3 in human dendritic cells","volume":"171","author":"Matsumoto","year":"2003","journal-title":"J. Immunol"},{"key":"2025010703513471100_r19","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1038\/ncomms7280","article-title":"Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo","volume":"6","author":"Matsumoto","year":"2015","journal-title":"Nat. Commun"},{"key":"2025010703513471100_r20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni886","article-title":"TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction","volume":"4","author":"Oshiumi","year":"2003","journal-title":"Nat. Immunol"},{"key":"2025010703513471100_r21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbrc.2018.10.166","article-title":"Vaccine adjuvant ARNAX promotes mucosal IgA production in influenza HA vaccination","volume":"506","author":"Takeda","year":"2018","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"2025010703513471100_r22","doi-asserted-by":"crossref","first-page":"e0172321","DOI":"10.1128\/mBio.01723-21","article-title":"Viral suppression of RIPK1-mediated signaling","volume":"12","author":"Udawatte","year":"2021","journal-title":"MBio"},{"key":"2025010703513471100_r23","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.celrep.2017.05.015","article-title":"A TLR3-specific adjuvant relieves innate resistance to PD-L1 blockade without cytokine toxicity in tumor vaccine immunotherapy","volume":"19","author":"Takeda","year":"2017","journal-title":"Cell Rep"},{"key":"2025010703513471100_r24","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/cas.13649","article-title":"Vaccine immunotherapy with ARNAX induces tumor-specific memory T cells and durable anti-tumor immunity in mouse models","volume":"109","author":"Takeda","year":"2018","journal-title":"Cancer Sci"},{"key":"2025010703513471100_r25","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3389\/fimmu.2017.01897","article-title":"Toll-like receptor 3 signal in dendritic cells benefits cancer immunotherapy","volume":"8","author":"Matsumoto","year":"2017","journal-title":"Front. Immunol"},{"key":"2025010703513471100_r26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.virol.2005.04.032","article-title":"Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus","volume":"337","author":"Rutigliano","year":"2005","journal-title":"Virology"},{"key":"2025010703513471100_r27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fimmu.2018.00323","article-title":"Induction and subversion of human protective immunity: contrasting influenza and respiratory syncytial virus","volume":"9","author":"Ascough","year":"2018","journal-title":"Front. Immunol"},{"key":"2025010703513471100_r28","doi-asserted-by":"crossref","first-page":"e1009668","DOI":"10.1371\/journal.ppat.1009668","article-title":"Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques","volume":"17","author":"Nomura","year":"2021","journal-title":"PLoS Pathog"},{"key":"2025010703513471100_r29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41579-020-00462-y","article-title":"Learning from the past: development of safe and effective COVID-19 vaccines","volume":"19","author":"Su","year":"2021","journal-title":"Nat. Rev. Microbiol"},{"key":"2025010703513471100_r30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41577-021-00522-1","article-title":"The first 12 months of COVID-19: a timeline of immunological insights","volume":"21","author":"Carvalho","year":"2021","journal-title":"Nat. Rev. Immunol"},{"key":"2025010703513471100_r31","doi-asserted-by":"crossref","first-page":"eabe0948","DOI":"10.1126\/scitranslmed.abe0948","article-title":"Prospects for a safe COVID-19 vaccine","volume":"12","author":"Haynes","year":"2020","journal-title":"Sci. Transl. Med"},{"key":"2025010703513471100_r32","doi-asserted-by":"crossref","first-page":"eabh3827","DOI":"10.1126\/sciadv.abh3827","article-title":"A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection","volume":"8","author":"Iwata-Yoshikawa","year":"2022","journal-title":"Sci. Adv"},{"key":"2025010703513471100_r33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/mi.2017.48","article-title":"Toll-like receptor 3 in nasal CD103+ dendritic cells is involved in immunoglobulin A production","volume":"11","author":"Takaki","year":"2018","journal-title":"Mucosal Immunol"},{"key":"2025010703513471100_r34","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4049\/jimmunol.161.3.1313","article-title":"Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response","volume":"161","author":"Wykes","year":"1998","journal-title":"J. Immunol"},{"key":"2025010703513471100_r35","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/intimm\/dxn021","article-title":"Requirements for the natural killer cell-mediated induction of IgG1 and IgG2a expression in B lymphocytes","volume":"20","author":"Gao","year":"2008","journal-title":"Int. Immunol"},{"key":"2025010703513471100_r36","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1084\/jem.20080979","article-title":"Dual role for B-1a cells in immunity to influenza virus infection","volume":"205","author":"Choi","year":"2008","journal-title":"J. Exp. Med"},{"key":"2025010703513471100_r37","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.immuni.2017.10.009","article-title":"CD4+ T cell help confers a cytotoxic T cell effector program including coinhibitory receptor downregulation and increased tissue invasiveness","volume":"47","author":"Ahrends","year":"2017","journal-title":"Immunity"},{"key":"2025010703513471100_r38","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1084\/jem.20190493","article-title":"Regulatory roles of IL-10-producing human follicular T cells","volume":"216","author":"Ca\u00f1ete","year":"2019","journal-title":"J. Exp. Med"},{"key":"2025010703513471100_r39","doi-asserted-by":"crossref","first-page":"e1010085","DOI":"10.1371\/journal.ppat.1010085","article-title":"Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens","volume":"17","author":"Uraki","year":"2021","journal-title":"PLoS Pathog"}],"container-title":["ImmunoHorizons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article-pdf\/6\/4\/275\/60186769\/ih2200020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article-pdf\/6\/4\/275\/60186769\/ih2200020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T03:57:10Z","timestamp":1736222230000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article\/6\/4\/275\/7816737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.4049\/immunohorizons.2200020","relation":{},"ISSN":["2573-7732"],"issn-type":[{"value":"2573-7732","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4]]},"published":{"date-parts":[[2022,4,1]]}}}